Related Experiment Video
Updated: Jun 14, 2026

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
Blood-brain barrier breakdown as a novel mechanism underlying cerebral hyperperfusion syndrome
Sebastian Ivens1, Szendro Gabriel, George Greenberg
1Institute of Neurophysiology, Neurocure Research Center, Charité Universitätsmedizin, Berlin, Germany.
Abstract:
Cerebral hyperperfusion syndrome (CHS) may occur as a severe complication following surgical treatment of carotid stenosis. However, the mechanism inducing neurological symptoms in CHS remains unknown. We describe a patient with CHS presenting with seizures 24 h following carotid endarterectomy. Imaging demonstrated early ipsilateral blood-brain barrier (BBB) breakdown with electroencephalographic evidence of cortical dysfunction preceding brain edema. Using in vitro experiments on rat cortical tissue, we show that direct exposure of isolated brain slices to a serum-like medium induces spontaneous epileptiform activity, and that neuronal dysfunction is triggered by albumin. We propose BBB breakdown and subsequent albumin extravasation as a novel pathogenic mechanism underlying CHS and a potential target for therapy.
More Related Videos
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology
The Blood-brain Barrier
Cytotoxic Edema: Pathophysiology
Cerebral Edema l: Introduction

